Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression After Osimertinib Treatment
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Zorifertinib With Osimertinib for NSCLC With Meningeal Progression (NCT07361705) | Alpha Biopharma (Jiangsu) Co., Ltd. | 2026-01-31 |
Track Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression After Osimertinib Treatment automatically
Every clearance here is in the API, with alerts when new ones post.